NEW YORK, July 10 - Applied Biosystems said Tuesday that it expects its revenue from instrument sales in the fiscal fourth quarter of 2001 to drop 12 percent to $192 million compared with $217 million in the year-ago quarter.

The company blamed the current economic slowdown for the decrease as well as an instrument glut because its customers bought "record-high" numbers of its instruments in the prior fiscal year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.